Substituting carmustine for lomustine is safe and effective in the treatment of relapsed or refractory Lymphoma-a retrospective study from the BSBMT (BEAM versus LEAM).
Resource Type
Editorial & Opinion
Authors
Kelsey P; Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK. philippakelsey1@nhs.net.; Pearce R; British Society of Blood and Marrow Transplantation, London, UK.; Perry J; British Society of Blood and Marrow Transplantation, London, UK.; Kirkland K; British Society of Blood and Marrow Transplantation, London, UK.; Paul R; British Society of Blood and Marrow Transplantation, London, UK.; Lambert J; University College London Hospitals NHS Foundation Trust, London, UK.; Peniket A; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Malladi R; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.; Snowden JA; Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.; Morley N; Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Source
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE